Similarly, meta-analysis has demonstrated higher NfL and GFAP in COVID-19 patients compared with healthy controls, and an association between these serum brain injury markers and COVID-19 severity and poorer outcomes35. The gene discussed is GFAP; the disease is COVID-19.